Furthermore, incubation of cells with curcumin, a potent immunomodulating therapeutic natural compound in AD, prevents PGE2 from suppressing fAβ42-elicited phagocytosis, through the inhibition of EP2 activity or its downstream cAMP-PKA-CREB signaling. This evidence concerns the gene CREB1 and Alzheimer disease.